Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Clin Chem. 2012 Sep 20;58(11):1582–1591. doi: 10.1373/clinchem.2012.190322

Table 2.

GDF-15 concentrations (ng/L) in 1,159 apparently healthy FHS participants without major cardiovascular, renal, or pulmonary disease

Age Percentile
Group
(years)
n 2.5th 10th 50th 90th 97.5th
Men 30–39 19 473 483 651 1,197 1,498
40–49 121 535 571 726 1,081 1,250
50–59 197 574 655 863 1,414 1,838
60–69 104 723 805 1,115 1,711 2,197
70–79 27 893 1,084 1,389 2,030 5,006
Women 30–39 14 520 543 745 1,007 1,085
40–49 180 488 561 762 1,172 1,574
50–59 275 557 668 890 1,269 1,786
60–69 167 652 784 1,025 1,553 1,833
70–79 55 845 939 1,277 1,717 2,562
HHS Vulnerability Disclosure